Top Markets
Coin of the day
Akums Drugs & Pharmaceuticals Ltd. Akums Drugs & Pharmaceuticals Ltd.

Akums Drugs & Pharmaceuticals Ltd.

AKUMS
Rang in Aktien #8292
Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in... Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).
Aktienkurs
$8.53
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$1.31B
Veränderung (1 Tag)
1.50%
Veränderung (1 Jahr)
65.49%
Land
IN
Handel Akums Drugs & Pharmaceuticals Ltd. (AKUMS)

Kategorie

Aktien-Split-Historie für Akums Drugs & Pharmaceuticals Ltd. (AKUMS)
Die Aktie Akums Drugs & Pharmaceuticals Ltd. (Symbol: AKUMS) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 29, 2026 statt.
Eine AKUMS-Aktie, die vor dem Aug 29, 2026 gekauft wurde, entspricht heute 0 AKUMS-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber